Universitätsklinikum Hamburg-Eppendorf (UKE)

Hospital


Location: Hamburg, Germany (DE) DE

ISNI: 0000000121803484

ROR: https://ror.org/01zgy1s35

Show on Map:


close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Rheumatism and the spine (2017) Swoboda B, Ruether W Journal article Secukinumab Treatment of moderate to severe Plaque Psoriasis in the clinical Routine Care: Baseline Data from the PROSPECT Study on Psoriasis Pre-treatment (2017) Von Kiedrowski R, Korber A, Kraehn-Senftleben G, Sticherling M, Lange L, Bachhuber T, Kasparek TR, et al. Conference contribution Secukinumab is superior to Fumaric Acid Esters in the Treatment of Patients with moderate to severe Plaque Psoriasis without previous Systemic Therapy for Improvement of Skin Symptoms: PASI and IGA mod. 2011-Results of the PRIME Study (2017) Reich K, Mrowietz U, Augustin M, Thaci D, Kneidl J, Hentschke C, Simang M, et al. Conference contribution Secukinumab is superior to Fumaric Acid Esters in the Treatment of Patients with moderate to severe Plaque Psoriasis without prior System Therapy with respect to the Improvement of quality of life: DLQI and SF-36 Results of the PRIME Study (2017) Augustin M, Thaci D, Reich K, Mrowietz U, Kneidl J, Hentschke C, Simang M, et al. Conference contribution SOP-palliative sedation (2017) Oechsle K, Radbruch L, Wolf C, Ostgathe C Journal article Secukinumab is superior to Fumaric Acid Esters in the Treatment of Patients with moderate to severe Plaque Psoriasis without prior System Therapy with regard to compatibility-related Therapeutic Adherence: Safety Results of the PRIME Study (2017) Mrowietz U, Augustin M, Thaci D, Reich K, Kneidl J, Hentschke C, Simang M, et al. Conference contribution Secukinumab is superior to Fumaric Acid Esters in the Treatment of Patients with moderate to severe Plaque Psoriasis with without previous Systemic Therapy for Improvement of Nail Symptoms: NAPSI Results PRIME Study (2017) Thaci D, Reich K, Mrowietz U, Augustin M, Kneidl J, Hentschke C, Simang M, et al. Conference contribution SOP - Dealing with multidrug-resistant pathogens on the palliative care unit (2017) Ostgathe C, Stachura P, Hofmann S, Van Oorschot B, Oechsle K, Bogdan C, Kunz HB, et al. Journal article Influence of radiotherapy-induced reactive oxygen species on the immunogenic potential of HPV+ in comparison to HPV- HNSCC (2017) Peitz L, Frey B, Rieckmann T, Fietkau R, Gaipl U Conference contribution A multidisciplinary systematic review of the treatment for chronic idiopathic tinnitus (2017) Zenner HP, Delb W, Kroener-Herwig B, Jaeger B, Peroz I, Hesse G, Mazurek B, et al. Journal article